BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 870919 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870920 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C29H28Cl2FNO4/c1-27(2,36)20-13-23-25(24(32)14-20)29(19-5-9-22(31)10-6-19,37-17-28(16-34)11-12-28)33(26(23)35)15-18-3-7-21(30)8-4-18/h3-10,13-14,34,36H,11-12,15-17H2,1-2H3/t29-/m1/s1 QUBUREFIXVDKEB-GDLZYMKVSA-N 427047 US10544132, Example 2::US10981898, Example 2::US11236047, Example 2 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427047&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281669 434321364 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870921 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCO)c1ccc(Cl)cc1 InChI=1S/C26H25Cl2NO4/c1-25(2,32)19-7-12-23-22(15-19)24(31)29(16-17-3-8-20(27)9-4-17)26(23,33-14-13-30)18-5-10-21(28)11-6-18/h3-12,15,30,32H,13-14,16H2,1-2H3/t26-/m1/s1 BDOTXISZENQYGP-AREMUKBSSA-N 427048 US10544132, Example 3::US10981898, Example 3::US11236047, Example 3 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 93.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427048&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281430 434321365 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870922 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(2,35)21-7-12-25-24(13-21)26(34)32(14-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)37-18-28(15-33)16-36-17-28/h3-13,33,35H,14-18H2,1-2H3/t29-/m1/s1 GDUHFOYTYPKEOT-GDLZYMKVSA-N 427049 US10544132, Example 4::US10981898, Example 4::US11236047, Example 4 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 43.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427049&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281482 434321366 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870923 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C(O)=O)c1ccc(Cl)cc1 InChI=1S/C29H27Cl2NO5/c1-27(2,36)20-7-12-24-23(15-20)25(33)32(16-18-3-8-21(30)9-4-18)29(24,19-5-10-22(31)11-6-19)37-17-28(13-14-28)26(34)35/h3-12,15,36H,13-14,16-17H2,1-2H3,(H,34,35)/t29-/m1/s1 IAJLMKLNFWIPMA-GDLZYMKVSA-N 427050 US10544132, Example 5::US10981898, Example 5::US11236047, Example 5 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 140 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427050&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281515 434321367 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870924 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC(C)(O)CO)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO5/c1-18(19-5-10-22(30)11-6-19)32-26(34)24-15-21(27(2,3)35)9-14-25(24)29(32,37-17-28(4,36)16-33)20-7-12-23(31)13-8-20/h5-15,18,33,35-36H,16-17H2,1-4H3/t18-,28?,29+/m0/s1 UUZINBSIYDKSFT-PDIMESBLSA-N 427051 US10544132, Example 6::US10981898, Example 6::US11236047, Example 6 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427051&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281509 434321368 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870925 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-19(20-4-9-23(31)10-5-20)33-27(35)25-16-22(28(2,3)36)8-13-26(25)30(33,21-6-11-24(32)12-7-21)37-18-29(17-34)14-15-29/h4-13,16,19,34,36H,14-15,17-18H2,1-3H3/t19-,30+/m0/s1 OBIKGGOHRXESCS-WWOZWPLTSA-N 427053 US10544132, Example 7::US10981898, Example 7::US11236047, Example 7 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.60 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427053&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281662 434321370 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870926 C[C@](O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27-,29+/m0/s1 NVLQHQFGNPTQCC-LMSSTIIKSA-N 427054 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(1,2-dihydroxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 8::US10981898, Example 8 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.70 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427054&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732949 434321371 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870927 C[C@@](O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-27(36,16-33)21-6-11-25-24(14-21)26(35)32(15-19-2-7-22(30)8-3-19)29(25,20-4-9-23(31)10-5-20)37-18-28(17-34)12-13-28/h2-11,14,33-34,36H,12-13,15-18H2,1H3/t27-,29-/m1/s1 NVLQHQFGNPTQCC-XRKRLSELSA-N 427055 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(1,2-dihydroxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 9::US10981898, Example 9 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427055&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732950 434321372 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870928 COC[C@](C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29-,31+/m0/s1 UIFBZUZURMPJLE-CRIGUBNMSA-N 427056 (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 10::US10981898, Example 10 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.70 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427056&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732951 434321373 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870929 COC[C@@](C)(O)c1ccc2c(c1)C(=O)N([C@@H](C)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2NO5/c1-20(21-4-9-24(32)10-5-21)34-28(36)26-16-23(29(2,37)18-38-3)8-13-27(26)31(34,22-6-11-25(33)12-7-22)39-19-30(17-35)14-15-30/h4-13,16,20,35,37H,14-15,17-19H2,1-3H3/t20-,29+,31+/m0/s1 UIFBZUZURMPJLE-XCIXRLFOSA-N 427057 (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 11::US10981898, Example 11 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 33.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427057&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732952 434321374 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870930 CN(C)C[C@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29-,31+/m0/s1 FLSKRFKVCWLISS-IGYGKHONSA-N 427058 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[1-(dimethylamino)-2-hydroxypropan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 12::US10981898, Example 13 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.80 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427058&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732953 434321375 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870931 CN(C)C[C@@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H34Cl2N2O4/c1-29(38,18-34(2)3)23-8-13-27-26(16-23)28(37)35(17-21-4-9-24(32)10-5-21)31(27,22-6-11-25(33)12-7-22)39-20-30(19-36)14-15-30/h4-13,16,36,38H,14-15,17-20H2,1-3H3/t29-,31-/m1/s1 FLSKRFKVCWLISS-BVRKHOPBSA-N 427060 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[1-(dimethylamino)-2-hydroxypropan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 13::US10981898, Example 12 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427060&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732954 434321377 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870932 CC(C)(O)c1ccc2c(c1)C(=O)N([C@@H](CC(O)=O)c1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2NO6/c1-29(2,39)21-7-12-25-24(15-21)28(38)34(26(16-27(36)37)19-3-8-22(32)9-4-19)31(25,20-5-10-23(33)11-6-20)40-18-30(17-35)13-14-30/h3-12,15,26,35,39H,13-14,16-18H2,1-2H3,(H,36,37)/t26-,31+/m0/s1 ZJSPHSZNTWLUQB-SUYBVONHSA-N 427061 US10544132, Example 14::US10981898, Example 14::US11236047, Example 14 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.00 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427061&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405302 434321378 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870933 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(O)CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO5/c1-19(20-3-8-23(31)9-4-20)33-27(36)25-15-22(28(2,37)16-34)7-12-26(25)30(33,21-5-10-24(32)11-6-21)38-18-29(17-35)13-14-29/h3-12,15,19,34-35,37H,13-14,16-18H2,1-2H3/t19-,28?,30+/m0/s1 HLYNUXSLMMUNHC-WDWHWGHSSA-N 427062 US10544132, Example 15::US10981898, Example 15::US11236047, Example 15 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 19.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427062&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281406 434321379 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870934 CC(C)(O)CCO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H31Cl2NO4/c1-27(2,34)15-16-36-29(20-7-12-23(31)13-8-20)25-14-9-21(28(3,4)35)17-24(25)26(33)32(29)18-19-5-10-22(30)11-6-19/h5-14,17,34-35H,15-16,18H2,1-4H3/t29-/m1/s1 QFAIKCYCAGIEDP-GDLZYMKVSA-N 427063 US10544132, Example 16::US10981898, Example 16::US11236047, Example 16 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 140 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427063&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281465 434321380 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870935 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)C2(OCc1cn[nH]c1)c1ccc(Cl)cc1 427064 US10544132, Example 17 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 63.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427064&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 142440544 434321381 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870936 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CC1)C#N)c1ccc(Cl)cc1 InChI=1S/C29H26Cl2N2O3/c1-27(2,35)21-7-12-25-24(15-21)26(34)33(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-32)13-14-28/h3-12,15,35H,13-14,16,18H2,1-2H3/t29-/m1/s1 CHHGWWCMCGHFMJ-GDLZYMKVSA-N 427065 US10544132, Example 18::US10981898, Example 18::US11236047, Example 18 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 45.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427065&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281503 434321382 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870937 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CNS(C)(=O)=O)CC1)c1ccc(Cl)cc1 InChI=1S/C30H32Cl2N2O5S/c1-28(2,36)22-8-13-26-25(16-22)27(35)34(17-20-4-9-23(31)10-5-20)30(26,21-6-11-24(32)12-7-21)39-19-29(14-15-29)18-33-40(3,37)38/h4-13,16,33,36H,14-15,17-19H2,1-3H3/t30-/m1/s1 FDNNWFOMKUDPQB-SSEXGKCCSA-N 427066 US10544132, Example 19 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 22.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427066&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281434 434321383 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870938 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#C)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H30ClNO4/c1-4-21-5-7-22(8-6-21)18-33-28(35)26-17-24(29(2,3)36)11-14-27(26)31(33,23-9-12-25(32)13-10-23)37-20-30(19-34)15-16-30/h1,5-14,17,34,36H,15-16,18-20H2,2-3H3/t31-/m1/s1 LTEBUYNLVXWZOS-WJOKGBTCSA-N 427067 US10544132, Example 20::US11236047, Example 20 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 11.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427067&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search U3Z 7BMG 135281739 434321384 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870939 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO4/c1-4-20-5-7-21(8-6-20)17-34-28(36)25-15-23(29(2,3)37)16-26(33)27(25)31(34,22-9-11-24(32)12-10-22)38-19-30(18-35)13-14-30/h1,5-12,15-16,35,37H,13-14,17-19H2,2-3H3/t31-/m1/s1 NBPAQCMFLGCFBK-WJOKGBTCSA-N 427068 US10544132, Example 21::US10544132, Example 24::US11236047, Example 21 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.80 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427068&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281734 434321385 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870940 C[C@](O)(CO)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO5/c1-3-20-4-6-21(7-5-20)16-34-28(37)25-14-23(29(2,38)17-35)15-26(33)27(25)31(34,22-8-10-24(32)11-9-22)39-19-30(18-36)12-13-30/h1,4-11,14-15,35-36,38H,12-13,16-19H2,2H3/t29-,31+/m0/s1 LDOCNQIRVXHZQU-IGYGKHONSA-N 427069 (3R)-3-(4-chlorophenyl)-6-(1,2-dihydroxypropan-2-yl)-2-[(4-ethynylphenyl)methyl]-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 22 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.20 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427069&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732955 434321386 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870941 CC(C)(O)c1cc2C(=O)N(Cc3ccc(cc3)C#C)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29ClFNO4/c1-4-20-5-7-21(8-6-20)17-34-28(36)25-15-23(29(2,3)37)16-26(33)27(25)31(34,22-9-11-24(32)12-10-22)38-19-30(18-35)13-14-30/h1,5-12,15-16,35,37H,13-14,17-19H2,2-3H3/t31-/m1/s1 NBPAQCMFLGCFBK-WJOKGBTCSA-N 427068 US10544132, Example 21::US10544132, Example 24::US11236047, Example 21 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.50 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427068&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281734 434321385 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870942 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29ClN2O4/c1-28(2,36)23-9-12-26-25(15-23)27(35)33(17-21-5-3-20(16-32)4-6-21)30(26,22-7-10-24(31)11-8-22)37-19-29(18-34)13-14-29/h3-12,15,34,36H,13-14,17-19H2,1-2H3/t30-/m1/s1 KUYDFZZMIJDWQY-SSEXGKCCSA-N 427071 US10544132, Example 25::US10981898, Example 25::US11236047, Example 25 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.20 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427071&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281419 434321387 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870943 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(C)COC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,34)21-8-13-25-24(14-21)26(33)32(15-19-4-9-22(30)10-5-19)29(25,20-6-11-23(31)12-7-20)36-18-28(3)16-35-17-28/h4-14,34H,15-18H2,1-3H3/t29-/m1/s1 JPJMGSQFTCZFQV-GDLZYMKVSA-N 427072 US10544132, Example 26::US10981898, Example 26::US11236047, Example 26 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 32.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427072&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281408 434321388 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870944 C[C@](O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@]2(C)OCC1(CO)CC1 InChI=1S/C25H28N2O5/c1-23(31,14-28)19-7-8-21-20(11-19)22(30)27(13-18-5-3-17(12-26)4-6-18)24(21,2)32-16-25(15-29)9-10-25/h3-8,11,28-29,31H,9-10,13-16H2,1-2H3/t23-,24+/m0/s1 RGPOYMGRXRWDFL-BJKOFHAPSA-N 427073 4-{[(1R)-1-(4-chlorophenyl)-5-(1,2-dihydroxypropan-2-yl)-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 27 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 65.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427073&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732956 434321389 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870945 CC(O)(CO)c1ccc2c(c1)C(=O)N(Cc1ccc(cc1)C#N)[C@]2(C)OCC1(CO)CC1 InChI=1S/C25H28N2O5/c1-23(31,14-28)19-7-8-21-20(11-19)22(30)27(13-18-5-3-17(12-26)4-6-18)24(21,2)32-16-25(15-29)9-10-25/h3-8,11,28-29,31H,9-10,13-16H2,1-2H3/t23?,24-/m1/s1 RGPOYMGRXRWDFL-XMMISQBUSA-N 427074 4-{[(1R)-1-(4-chlorophenyl)-5-(1,2-dihydroxypropan-2-yl)-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 28 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427074&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765548 434321390 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870946 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(O)CC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-26(2,33)20-7-12-24-23(15-20)25(32)31(16-18-3-8-21(29)9-4-18)28(24,35-17-27(34)13-14-27)19-5-10-22(30)11-6-19/h3-12,15,33-34H,13-14,16-17H2,1-2H3/t28-/m1/s1 RCIVCEHJWTYZDO-MUUNZHRXSA-N 427075 US10544132, Example 29::US11236047, Example 29 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 110 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427075&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281489 434321391 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870947 CN(C)C(=O)CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C28H28Cl2N2O4/c1-27(2,35)20-9-14-24-23(15-20)26(34)32(16-18-5-10-21(29)11-6-18)28(24,36-17-25(33)31(3)4)19-7-12-22(30)13-8-19/h5-15,35H,16-17H2,1-4H3/t28-/m1/s1 RRQCJUUJERJVBP-MUUNZHRXSA-N 427076 US10544132, Example 30::US11236047, Example 30 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 86.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427076&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281547 434321392 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870948 COCC1(CO[C@]2(N(Cc3ccc(Cl)cc3)C(=O)c3cc(ccc23)C(C)(C)O)c2ccc(Cl)cc2)CC1 InChI=1S/C30H31Cl2NO4/c1-28(2,35)22-8-13-26-25(16-22)27(34)33(17-20-4-9-23(31)10-5-20)30(26,21-6-11-24(32)12-7-21)37-19-29(14-15-29)18-36-3/h4-13,16,35H,14-15,17-19H2,1-3H3/t30-/m1/s1 RARQEPSEJKMFPX-SSEXGKCCSA-N 427077 US10544132, Example 31::US10981898, Example 31::US11236047, Example 31 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 38.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427077&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281414 434321393 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870949 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1C(O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2NO6/c1-28(2,38)20-6-10-25-24(13-20)26(35)33(15-18-3-7-22(32)14-23(18)27(36)37)30(25,19-4-8-21(31)9-5-19)39-17-29(16-34)11-12-29/h3-10,13-14,34,38H,11-12,15-17H2,1-2H3,(H,36,37)/t30-/m1/s1 NQWVLAWWWVVUAN-SSEXGKCCSA-N 427078 US10544132, Example 33::US11236047, Example 33 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427078&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281410 434321394 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870950 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(=O)(=O)N1CCOCC1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H36Cl2N2O7S/c1-31(2,40)24-6-10-28-27(17-24)30(39)37(33(28,23-4-8-25(34)9-5-23)44-21-32(20-38)11-12-32)19-22-3-7-26(35)18-29(22)45(41,42)36-13-15-43-16-14-36/h3-10,17-18,38,40H,11-16,19-21H2,1-2H3/t33-/m1/s1 JFAQMYZAZWRRKT-MGBGTMOVSA-N 427079 US10544132, Example 34::US11236047, Example 34 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427079&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281697 434321395 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870951 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)C(OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H29Cl2FN2O6S/c1-28(2,38)19-12-22-25(23(33)13-19)30(18-5-8-20(31)9-6-18,41-16-29(10-11-29)27(34)37)35(26(22)36)15-17-4-7-21(32)14-24(17)42(3,39)40/h4-9,12-14,38H,10-11,15-16H2,1-3H3,(H2,34,37) QXTIAAQSOXPAAN-UHFFFAOYSA-N 427080 US10544132, Example 35 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427080&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732957 434321396 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870952 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1S(C)(=O)=O)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO6S/c1-28(2,36)21-7-11-25-24(14-21)27(35)33(16-19-4-8-23(32)15-26(19)40(3,37)38)30(25,20-5-9-22(31)10-6-20)39-18-29(17-34)12-13-29/h4-11,14-15,34,36H,12-13,16-18H2,1-3H3/t30-/m1/s1 RXUWUIRMPWZSAR-SSEXGKCCSA-N 427081 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-3-({1-[hydroxy(2H2)methyl]cyclopropyl}(2H2)methoxy)-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 36::US10981898, Example 36::US11236047, Example 36 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427081&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732958 434321397 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870953 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(O[C@@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23-,28-/m1/s1 ITVICYXWRBVNRA-QDPGVEIFSA-N 427082 (3R)-3-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-(oxolan-3-yloxy)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 37::US10981898, Example 38 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 41.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427082&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732959 434321398 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870954 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(O[C@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C28H27Cl2NO4/c1-27(2,33)20-7-12-25-24(15-20)26(32)31(16-18-3-8-21(29)9-4-18)28(25,35-23-13-14-34-17-23)19-5-10-22(30)11-6-19/h3-12,15,23,33H,13-14,16-17H2,1-2H3/t23-,28+/m0/s1 ITVICYXWRBVNRA-NEKDWFFYSA-N 427083 (3R)-3-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-(oxolan-3-yloxy)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 38::US10981898, Example 37 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 26.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427083&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732960 434321399 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870955 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20-,29+/m0/s1 OTIYWWDOPCSJHZ-AFJIDDCJSA-N 427084 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-[(oxolan-3-yl)methoxy]-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 39::US10981898, Example 40 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 68.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427084&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732961 434321400 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870956 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@@H]1CCOC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-28(2,34)22-7-12-26-25(15-22)27(33)32(16-19-3-8-23(30)9-4-19)29(26,21-5-10-24(31)11-6-21)36-18-20-13-14-35-17-20/h3-12,15,20,34H,13-14,16-18H2,1-2H3/t20-,29-/m1/s1 OTIYWWDOPCSJHZ-ACSYHNTCSA-N 427085 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-(2-hydroxypropan-2-yl)-3-[(oxolan-3-yl)methoxy]-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 40::US10981898, Example 39 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 63.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427085&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732962 434321401 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870957 C[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO7S/c1-32(41,22-9-13-44-14-10-22)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,45-20-33(19-39)11-12-33)38(31(27)40)18-21-3-6-26(36)17-29(21)46(2,42)43/h3-8,15-17,22,39,41H,9-14,18-20H2,1-2H3/t32-,34-/m1/s1 JFGISRYCIHBUCK-ZFEZZJPFSA-N 427086 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 41::US10981898, Example 41 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.60 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427086&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732963 434321402 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870958 C[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO7S/c1-32(41,22-9-13-44-14-10-22)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,45-20-33(19-39)11-12-33)38(31(27)40)18-21-3-6-26(36)17-29(21)46(2,42)43/h3-8,15-17,22,39,41H,9-14,18-20H2,1-2H3/t32-,34+/m0/s1 JFGISRYCIHBUCK-UZNNEEJFSA-N 427087 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 42 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 34000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427087&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732964 434321403 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870959 C[C@@](O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H38Cl2FN3O6S/c1-32(43,19-39-13-11-38-12-14-39)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,46-21-33(20-41)9-10-33)40(31(27)42)18-22-3-6-26(36)17-29(22)47(2,44)45/h3-8,15-17,38,41,43H,9-14,18-21H2,1-2H3/t32-,34-/m1/s1 NTYHQRPYZXGTGT-ZFEZZJPFSA-N 427088 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(piperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 43 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 47000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427088&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732965 434321404 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870960 C[C@](O)(CN1CCNCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H38Cl2FN3O6S/c1-32(43,19-39-13-11-38-12-14-39)24-15-27-30(28(37)16-24)34(23-4-7-25(35)8-5-23,46-21-33(20-41)9-10-33)40(31(27)42)18-22-3-6-26(36)17-29(22)47(2,44)45/h3-8,15-17,38,41,43H,9-14,18-21H2,1-2H3/t32-,34+/m0/s1 NTYHQRPYZXGTGT-UZNNEEJFSA-N 427089 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(piperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 44::US10981898, Example 44 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.80 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427089&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732966 434321405 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870961 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OC1COC[C@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25+,26?,29+/m0/s1 JLJRDOGQKDSPHW-BKVJDPFESA-N 427090 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3S,4R)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one and (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3R,4S)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 45::US10981898, Example 45::US11236047, Example 45 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 230 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427090&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765588 434321406 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870962 C[C@H](N1C(=O)c2cc(ccc2[C@]1(OC1COC[C@@H]1O)c1ccc(Cl)cc1)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO5/c1-17(18-4-9-21(30)10-5-18)32-27(34)23-14-20(28(2,3)35)8-13-24(23)29(32,19-6-11-22(31)12-7-19)37-26-16-36-15-25(26)33/h4-14,17,25-26,33,35H,15-16H2,1-3H3/t17-,25-,26?,29+/m0/s1 JLJRDOGQKDSPHW-QYEDSFCJSA-N 427091 (3R)-3-(4-Chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3S,4R)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one and (3R)-3-(4-chlorophenyl)-2-[(1S)-1-(4-chlorophenyl)ethyl]-3-{[(3R,4S)-4-hydroxyoxolan-3-yl]oxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 46::US10981898, Example 46 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 10780 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427091&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732967 434321407 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870963 CO[C@]1(N(Cc2ccc(Cl)cc2)C(=O)c2cc(ccc12)C(C)(C)O)c1ccc(Cl)cc1 InChI=1S/C25H23Cl2NO3/c1-24(2,30)18-8-13-22-21(14-18)23(29)28(15-16-4-9-19(26)10-5-16)25(22,31-3)17-6-11-20(27)12-7-17/h4-14,30H,15H2,1-3H3/t25-/m1/s1 GBBKEWOTKMXEJW-RUZDIDTESA-N 427092 US10544132, Example 47::US10981898, Example 47::US11236047, Example 47 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 430 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427092&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281412 434321408 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870964 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C29H29Cl2NO4/c1-27(2,35)21-7-12-25-24(15-21)26(34)32(16-19-3-8-22(30)9-4-19)29(25,20-5-10-23(31)11-6-20)36-18-28(17-33)13-14-28/h3-12,15,33,35H,13-14,16-18H2,1-2H3/t29-/m1/s1 KWVOGOFTJBHEAY-GDLZYMKVSA-N 427023 US10544132, Example 1::US10544132, Example 48::US10981898, Example 48::US11236047, Example 48 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.30 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427023&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281635 434321340 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870965 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCCCO)c1ccc(Cl)cc1 InChI=1S/C27H27Cl2NO4/c1-26(2,33)20-8-13-24-23(16-20)25(32)30(17-18-4-9-21(28)10-5-18)27(24,34-15-3-14-31)19-6-11-22(29)12-7-19/h4-13,16,31,33H,3,14-15,17H2,1-2H3/t27-/m1/s1 OAZOTQYKBROZDC-HHHXNRCGSA-N 427095 US10544132, Example 49::US10981898, Example 49::US11236047, Example 49 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 82.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427095&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281478 434321410 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870966 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO6S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,40-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)41(3,38)39/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 UZPANWLGEIIIFW-SSEXGKCCSA-N 427098 US10544132, Example 50::US10981898, Example 62::US11236047, Example 50 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.800 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427098&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281647 434321413 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870967 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC(F)(F)CO)c1ccc(Cl)cc1 InChI=1S/C27H25Cl2F2NO4/c1-25(2,35)19-7-12-23-22(13-19)24(34)32(14-17-3-8-20(28)9-4-17)27(23,36-16-26(30,31)15-33)18-5-10-21(29)11-6-18/h3-13,33,35H,14-16H2,1-2H3/t27-/m1/s1 DKLIPENWHNVPEY-HHHXNRCGSA-N 427099 US10544132, Example 51::US10981898, Example 51::US11236047, Example 51 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 130 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427099&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281507 434321414 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870968 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21+,30+/m0/s1 YJPCYIKTKXDGAX-KSWJDTNCSA-N 427101 US10544132, Example 52::US10981898, Example 52::US11236047, Example 53 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 150 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427101&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411534 434321416 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870969 CC(C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OC[C@H]1CC[C@@H]1CO)c1ccc(Cl)cc1 InChI=1S/C30H31Cl2NO4/c1-29(2,36)23-9-14-27-26(15-23)28(35)33(16-19-3-10-24(31)11-4-19)30(27,22-7-12-25(32)13-8-22)37-18-21-6-5-20(21)17-34/h3-4,7-15,20-21,34,36H,5-6,16-18H2,1-2H3/t20-,21-,30-/m1/s1 YJPCYIKTKXDGAX-URCPOSBSSA-N 427102 US10544132, Example 53 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427102&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732968 434321417 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870970 CC(O)(C(=O)N1CCCC1)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2N2O5/c1-31(41,30(40)36-16-2-3-17-36)24-8-13-28-27(18-24)29(39)37(19-22-4-9-25(34)10-5-22)33(28,23-6-11-26(35)12-7-23)42-21-32(20-38)14-15-32/h4-13,18,38,41H,2-3,14-17,19-21H2,1H3/t31?,33-/m1/s1 AVCINXLMIYQZIG-NFCCVXSLSA-N 427103 (3R)-3-(4-chlorophenyl)-2-[(4-chlorophenyl)methyl]-6-[2-hydroxy-1-oxo-1-(pyrrolidin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 54::US11236047, Example 55 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 150 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427103&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281508 434321418 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870971 CN(C)C(=O)[C@@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29-,31+/m0/s1 QSQWTXWPCPYZCQ-IGYGKHONSA-N 427104 US10544132, Example 56::US10981898, Example 57 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 120 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427104&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732969 434321419 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870972 CN(C)C(=O)[C@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2N2O5/c1-29(39,28(38)34(2)3)22-8-13-26-25(16-22)27(37)35(17-20-4-9-23(32)10-5-20)31(26,21-6-11-24(33)12-7-21)40-19-30(18-36)14-15-30/h4-13,16,36,39H,14-15,17-19H2,1-3H3/t29-,31-/m1/s1 QSQWTXWPCPYZCQ-BVRKHOPBSA-N 427108 US10544132, Example 57::US10981898, Example 56 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 61.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427108&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732970 434321422 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870973 CNC(=O)[C@@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28-,30+/m0/s1 FLAAYSHQWIAMDD-MFMCTBQISA-N 427109 2-[(1R)-1-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-5-yl]-2-hydroxy-N-methylpropanamide::US10544132, Example 58::US10981898, Example 59 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427109&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732971 434321423 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870974 CNC(=O)[C@](C)(O)c1ccc2c(c1)C(=O)N(Cc1ccc(Cl)cc1)[C@@]2(OCC1(CO)CC1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2N2O5/c1-28(38,27(37)33-2)21-7-12-25-24(15-21)26(36)34(16-19-3-8-22(31)9-4-19)30(25,20-5-10-23(32)11-6-20)39-18-29(17-35)13-14-29/h3-12,15,35,38H,13-14,16-18H2,1-2H3,(H,33,37)/t28-,30-/m1/s1 FLAAYSHQWIAMDD-PQHLKRTFSA-N 427110 2-[(1R)-1-(4-Chlorophenyl)-2-[(4-chlorophenyl)methyl]-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-5-yl]-2-hydroxy-N-methylpropanamide::US10544132, Example 59::US10981898, Example 58 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.10 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427110&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732972 434321424 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870975 CSc1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO4S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,38-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)39-3/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-/m1/s1 OAWFYJRYUZCBKK-SSEXGKCCSA-N 427111 US10544132, Example 60::US10981898, Example 60::US11236047, Example 60 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 14.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427111&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281694 434321425 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870976 C[S@](=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO5S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,39-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)40(3)38/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-,40+/m1/s1 PVRYETGYPNIACM-FRRBMJAGSA-N 427113 (3R)-2-[(4-Chloro-2-methanesulfinylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 61 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 16.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427113&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732973 434321427 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870977 C[S@@](=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)C(C)(C)O InChI=1S/C30H30Cl2FNO5S/c1-28(2,37)20-12-23-26(24(33)13-20)30(19-5-8-21(31)9-6-19,39-17-29(16-35)10-11-29)34(27(23)36)15-18-4-7-22(32)14-25(18)40(3)38/h4-9,12-14,35,37H,10-11,15-17H2,1-3H3/t30-,40-/m1/s1 PVRYETGYPNIACM-HFOCTHEHSA-N 427115 (3R)-2-[(4-Chloro-2-methanesulfinylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-6-(2-hydroxypropan-2-yl)-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 62 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.30 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427115&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732974 434321429 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870978 COC[C@@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FNO7S/c1-29(38,17-41-2)21-12-24-27(25(34)13-21)31(20-5-8-22(32)9-6-20,42-18-30(16-36)10-11-30)35(28(24)37)15-19-4-7-23(33)14-26(19)43(3,39)40/h4-9,12-14,36,38H,10-11,15-18H2,1-3H3/t29-,31-/m1/s1 XPPOSVDBYKUPEU-BVRKHOPBSA-N 427116 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 63::US10981898, Example 64 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 71000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427116&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732975 434321430 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870979 COC[C@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H32Cl2FNO7S/c1-29(38,17-41-2)21-12-24-27(25(34)13-21)31(20-5-8-22(32)9-6-20,42-18-30(16-36)10-11-30)35(28(24)37)15-19-4-7-23(33)14-26(19)43(3,39)40/h4-9,12-14,36,38H,10-11,15-18H2,1-3H3/t29-,31+/m0/s1 XPPOSVDBYKUPEU-IGYGKHONSA-N 427117 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-(2-hydroxy-1-methoxypropan-2-yl)-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 64 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.10 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427117&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732976 434321431 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870980 C[C@@](O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28-,30-/m1/s1 HJVLHGXGDKFDKJ-PQHLKRTFSA-N 427118 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-6-(1,2-dihydroxypropan-2-yl)-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 65::US10981898, Example 65 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.80 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427118&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732977 434321432 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870981 C[C@](O)(CO)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H30Cl2FNO7S/c1-28(38,15-35)20-11-23-26(24(33)12-20)30(19-4-7-21(31)8-5-19,41-17-29(16-36)9-10-29)34(27(23)37)14-18-3-6-22(32)13-25(18)42(2,39)40/h3-8,11-13,35-36,38H,9-10,14-17H2,1-2H3/t28-,30+/m0/s1 HJVLHGXGDKFDKJ-MFMCTBQISA-N 427119 (3R)-2-[(4-Chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-6-(1,2-dihydroxypropan-2-yl)-4-fluoro-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 66::US10981898, Example 66 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 3.00 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427119&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732978 434321433 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870982 CN1CCN(C[C@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33+,34-/m1/s1 GEZPZMXREXHEJZ-LKDIDBIPSA-N 427120 US10544132, Example 67 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 60000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427120&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732979 434321434 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870983 CN1CCN(C[C@@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33-,34-/m1/s1 GEZPZMXREXHEJZ-WTWHSOPRSA-N 427121 US10544132, Example 68 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 7.00 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427121&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732980 434321435 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870984 CN1CCN(C[C@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33-,34+/m0/s1 GEZPZMXREXHEJZ-FBBJSWSOSA-N 427122 US10544132, Example 69::US10981898, Example 70 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.700 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427122&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732981 434321436 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870985 CN1CCN(C[C@@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](O[C@H]4CCOC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C34H38Cl2FN3O6S/c1-33(42,21-39-13-11-38(2)12-14-39)24-16-28-31(29(37)17-24)34(46-27-10-15-45-20-27,23-5-8-25(35)9-6-23)40(32(28)41)19-22-4-7-26(36)18-30(22)47(3,43)44/h4-9,16-18,27,42H,10-15,19-21H2,1-3H3/t27-,33+,34+/m0/s1 GEZPZMXREXHEJZ-HOMOBGQPSA-N 427123 US10544132, Example 70::US10981898, Example 69 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 5.70 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427123&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732982 434321437 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870986 CC(C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO6/c1-29(2,38)19-13-23-27(24(33)14-19)30(40-22-11-12-39-16-22,18-5-9-21(32)10-6-18)34(28(23)37)25(15-26(35)36)17-3-7-20(31)8-4-17/h3-10,13-14,22,25,38H,11-12,15-16H2,1-2H3,(H,35,36)/t22-,25-,30+/m0/s1 PMXGSEVMEXTCLI-SGOMLOLCSA-N 427124 US10544132, Example 71::US10981898, Example 71::US11236047, Example 71 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.00 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427124&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281459 434321438 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870987 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3CO)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H27Cl2FN2O4/c1-28(2,38)21-12-24-26(25(33)13-21)30(20-4-7-22(31)8-5-20,39-17-29(16-34)9-10-29)35(27(24)37)14-18-3-6-23(32)11-19(18)15-36/h3-8,11-13,36,38H,9-10,14-15,17H2,1-2H3/t30-/m1/s1 FZOWPLQXTSEWMX-SSEXGKCCSA-N 427125 US10544132, Example 72::US10981898, Example 72::US11236047, Example 72 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.50 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427125&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281421 434321439 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870988 Cn1cc(cn1)[C@@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31-,33+/m0/s1 YLXVSCUQMYZKFT-CQTOTRCISA-N 427126 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 73::US10981898, Example 73 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427126&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732983 434321440 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870989 Cn1cc(cn1)[C@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H31Cl2FN4O6S/c1-31(43,22-15-38-39(2)17-22)21-12-25-28(26(36)13-21)33(20-5-8-23(34)9-6-20,46-18-32(10-11-32)30(37)42)40(29(25)41)16-19-4-7-24(35)14-27(19)47(3,44)45/h4-9,12-15,17,43H,10-11,16,18H2,1-3H3,(H2,37,42)/t31-,33-/m1/s1 YLXVSCUQMYZKFT-ZQWAWDFXSA-N 427127 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 74::US10981898, Example 74 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.500 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427127&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732984 434321441 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870990 Cn1cc(cn1)[C@@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O6S/c1-30(40,22-15-36-37(2)17-22)21-12-25-28(26(35)13-21)32(44-18-31(41)10-11-31,20-5-8-23(33)9-6-20)38(29(25)39)16-19-4-7-24(34)14-27(19)45(3,42)43/h4-9,12-15,17,40-41H,10-11,16,18H2,1-3H3/t30-,32+/m0/s1 FATKFLNSLQQUOY-XDFJSJKPSA-N 427128 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3-[(1-hydroxycyclopropyl)methoxy]-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 75 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 73000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427128&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765602 434321442 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870991 Cn1cc(cn1)[C@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(O)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O6S/c1-30(40,22-15-36-37(2)17-22)21-12-25-28(26(35)13-21)32(44-18-31(41)10-11-31,20-5-8-23(33)9-6-20)38(29(25)39)16-19-4-7-24(34)14-27(19)45(3,42)43/h4-9,12-15,17,40-41H,10-11,16,18H2,1-3H3/t30-,32-/m1/s1 FATKFLNSLQQUOY-XLJNKUFUSA-N 427129 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(1-methyl-1H-pyrazol-4-yl)ethyl]-3-[(1-hydroxycyclopropyl)methoxy]-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 76 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 9.50 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427129&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765612 434321443 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870992 CN1CCN(C[C@@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OCC4(CO)CC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H40Cl2FN3O6S/c1-33(44,20-40-14-12-39(2)13-15-40)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,47-22-34(21-42)10-11-34)41(32(28)43)19-23-4-7-27(37)18-30(23)48(3,45)46/h4-9,16-18,42,44H,10-15,19-22H2,1-3H3/t33-,35-/m1/s1 UAASDXMLTUDYGD-VLZNPVHKSA-N 427130 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 77 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 61000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427130&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732985 434321444 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870993 CN1CCN(C[C@](C)(O)c2cc3C(=O)N(Cc4ccc(Cl)cc4S(C)(=O)=O)[C@](OCC4(CO)CC4)(c3c(F)c2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H40Cl2FN3O6S/c1-33(44,20-40-14-12-39(2)13-15-40)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,47-22-34(21-42)10-11-34)41(32(28)43)19-23-4-7-27(37)18-30(23)48(3,45)46/h4-9,16-18,42,44H,10-15,19-22H2,1-3H3/t33-,35+/m0/s1 UAASDXMLTUDYGD-QWOOXDRHSA-N 427131 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[2-hydroxy-1-(4-methylpiperazin-1-yl)propan-2-yl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 78 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.60 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427131&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732986 434321445 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870994 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(O)=O)[C@](OCC3(CC3)C#N)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C30H25Cl2FN2O5/c1-28(2,39)19-11-23-25(24(33)12-19)30(18-4-7-20(31)8-5-18,40-16-29(15-34)9-10-29)35(26(23)36)14-17-3-6-21(32)13-22(17)27(37)38/h3-8,11-13,39H,9-10,14,16H2,1-2H3,(H,37,38)/t30-/m1/s1 DEAVUDZEMMDBRA-SSEXGKCCSA-N 427132 US10544132, Example 79::US11236047, Example 79 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.20 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427132&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281403 434321446 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870995 CN1CCC(CC1)[C@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H39Cl2FN2O6S/c1-33(43,23-10-14-39(2)15-11-23)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,46-21-34(20-41)12-13-34)40(32(28)42)19-22-4-7-27(37)18-30(22)47(3,44)45/h4-9,16-18,23,41,43H,10-15,19-21H2,1-3H3/t33-,35+/m0/s1 MNUHQOFWGYDTKI-QWOOXDRHSA-N 427133 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(1-methylpiperidin-4-yl)ethyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 80 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 73000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427133&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732987 434321447 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870996 CN1CCC(CC1)[C@@](C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H39Cl2FN2O6S/c1-33(43,23-10-14-39(2)15-11-23)25-16-28-31(29(38)17-25)35(24-5-8-26(36)9-6-24,46-21-34(20-41)12-13-34)40(32(28)42)19-22-4-7-27(37)18-30(22)47(3,44)45/h4-9,16-18,23,41,43H,10-15,19-21H2,1-3H3/t33-,35-/m1/s1 MNUHQOFWGYDTKI-VLZNPVHKSA-N 427134 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[1-hydroxy-1-(1-methylpiperidin-4-yl)ethyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 81 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.60 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427134&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732988 434321448 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870997 CC(C)(O)c1cc2C(=O)N(Cc3ccc(Cl)cc3P(C)(C)=O)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H33Cl2FNO5P/c1-29(2,38)21-13-24-27(25(34)14-21)31(20-6-9-22(32)10-7-20,40-18-30(17-36)11-12-30)35(28(24)37)16-19-5-8-23(33)15-26(19)41(3,4)39/h5-10,13-15,36,38H,11-12,16-18H2,1-4H3/t31-/m1/s1 IARKWVZHJYWTDX-WJOKGBTCSA-N 427135 US10544132, Example 82::US10981898, Example 82::US11236047, Example 82 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 2.50 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427135&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405337 434321449 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870998 CS(=O)(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)[C@@H](O)C1CCOCC1 InChI=1S/C33H34Cl2FNO7S/c1-45(41,42)28-16-25(35)5-2-21(28)17-37-31(40)26-14-22(30(39)20-8-12-43-13-9-20)15-27(36)29(26)33(37,23-3-6-24(34)7-4-23)44-19-32(18-38)10-11-32/h2-7,14-16,20,30,38-39H,8-13,17-19H2,1H3/t30-,33+/m0/s1 IRIZYNABKNVLML-BZKUTMRRSA-N 427136 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[hydroxy(oxan-4-yl)methyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 83 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427136&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732989 434321450 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 870999 CS(=O)(=O)c1cc(Cl)ccc1CN1C(=O)c2cc(cc(F)c2[C@]1(OCC1(CO)CC1)c1ccc(Cl)cc1)[C@H](O)C1CCOCC1 InChI=1S/C33H34Cl2FNO7S/c1-45(41,42)28-16-25(35)5-2-21(28)17-37-31(40)26-14-22(30(39)20-8-12-43-13-9-20)15-27(36)29(26)33(37,23-3-6-24(34)7-4-23)44-19-32(18-38)10-11-32/h2-7,14-16,20,30,38-39H,8-13,17-19H2,1H3/t30-,33-/m1/s1 IRIZYNABKNVLML-LXANVCGNSA-N 427139 (3R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-3-(4-chlorophenyl)-4-fluoro-6-[hydroxy(oxan-4-yl)methyl]-3-{[1-(hydroxymethyl)cyclopropyl]methoxy}-2,3-dihydro-1H-isoindol-1-one::US10544132, Example 84::US10981898, Example 83 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 39000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427139&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732991 434321453 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871000 C[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32-,34-/m1/s1 WPEIHYLRRFWOGP-ZFEZZJPFSA-N 427143 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 85::US10981898, Example 85 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.490 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427143&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732993 434321457 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871001 C[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OCC3(CC3)C(N)=O)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H35Cl2FN2O7S/c1-32(42,21-9-13-45-14-10-21)23-15-26-29(27(37)16-23)34(22-4-7-24(35)8-5-22,46-19-33(11-12-33)31(38)41)39(30(26)40)18-20-3-6-25(36)17-28(20)47(2,43)44/h3-8,15-17,21,42H,9-14,18-19H2,1-2H3,(H2,38,41)/t32-,34+/m0/s1 WPEIHYLRRFWOGP-UZNNEEJFSA-N 427145 1-({[(1R)-2-[(4-chloro-2-methanesulfonylphenyl)methyl]-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-1-yl]oxy}methyl)cyclopropane-1-carboxamide::US10544132, Example 86::US10981898, Example 86 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 56000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427145&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732994 434321459 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871002 CO[C@]1(N(Cc2ccc(Cl)cc2C(O)=O)C(=O)c2cc(cc(F)c12)C(C)(O)C1CCN(C)CC1)c1ccc(Cl)cc1 InChI=1S/C31H31Cl2FN2O5/c1-30(40,19-10-12-35(2)13-11-19)21-14-25-27(26(34)15-21)31(41-3,20-5-8-22(32)9-6-20)36(28(25)37)17-18-4-7-23(33)16-24(18)29(38)39/h4-9,14-16,19,40H,10-13,17H2,1-3H3,(H,38,39)/t30?,31-/m1/s1 PGUDRRCAMVOBPY-NLIBRCFJSA-N 427146 US10544132, Example 87::US11236047, Example 87 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 82000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427146&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281456 434321460 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871003 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@@](C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30-,31+/m0/s1 AVDHVIXZENQIRS-HOSFBAFGSA-N 427147 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 88::US10981898, Example 88 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.790 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427147&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732995 434321461 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871004 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](C)(O)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-30(39,19-11-13-41-14-12-19)21-15-24-28(25(34)16-21)31(40-2,20-5-9-23(33)10-6-20)35(29(24)38)26(17-27(36)37)18-3-7-22(32)8-4-18/h3-10,15-16,19,26,39H,11-14,17H2,1-2H3,(H,36,37)/t26-,30+,31+/m0/s1 AVDHVIXZENQIRS-MAJWKWKESA-N 427148 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(oxan-4-yl)ethyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 89::US10981898, Example 89 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427148&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732996 434321462 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871005 CC[C@@](O)(c1cn(C)cn1)c1cc2C(=O)N([C@@H](CO)c3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)24-14-27-31(28(36)15-24)34(45-26-12-13-44-19-26,23-8-10-25(35)11-9-23)40(32(27)42)29(18-41)22-6-4-21(16-37)5-7-22/h4-11,14-15,17,20,26,29,41,43H,3,12-13,18-19H2,1-2H3/t26-,29-,33-,34+/m0/s1 DLDOXTZEZBHSKM-PRLHHBRKSA-N 427149 4-[(1R)-1-[(1R)-1-(4-Chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]-2-hydroxyethyl]benzonitrile::US10544132, Example 90 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 39000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427149&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732997 434321463 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871006 CC[C@](O)(c1cn(C)cn1)c1cc2C(=O)N([C@@H](CO)c3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)24-14-27-31(28(36)15-24)34(45-26-12-13-44-19-26,23-8-10-25(35)11-9-23)40(32(27)42)29(18-41)22-6-4-21(16-37)5-7-22/h4-11,14-15,17,20,26,29,41,43H,3,12-13,18-19H2,1-2H3/t26-,29-,33+,34+/m0/s1 DLDOXTZEZBHSKM-ZZQNMKAFSA-N 427150 4-[(1R)-1-[(1R)-1-(4-Chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]-2-hydroxyethyl]benzonitrile::US10544132, Example 91 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 78000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427150&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732998 434321464 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871007 CC[C@@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3CO)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)25-13-28-31(29(36)14-25)34(45-27-10-11-44-19-27,24-6-8-26(35)9-7-24)40(32(28)42)16-22-5-4-21(15-37)12-23(22)18-41/h4-9,12-14,17,20,27,41,43H,3,10-11,16,18-19H2,1-2H3/t27-,33-,34+/m0/s1 LQLKHTDURGSYEY-FBBJSWSOSA-N 427152 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[I-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]methyl}-3-(hydroxymethyl)benzonitrile::US10544132, Example 92 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 76000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427152&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154732999 434321466 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871008 CC[C@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3CO)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O5/c1-3-33(43,30-17-39(2)20-38-30)25-13-28-31(29(36)14-25)34(45-27-10-11-44-19-27,24-6-8-26(35)9-7-24)40(32(28)42)16-22-5-4-21(15-37)12-23(22)18-41/h4-9,12-14,17,20,27,41,43H,3,10-11,16,18-19H2,1-2H3/t27-,33+,34+/m0/s1 LQLKHTDURGSYEY-HOMOBGQPSA-N 427153 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[I-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]methyl}-3-(hydroxymethyl)benzonitrile::US10544132, Example 93 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 49000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427153&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733000 434321467 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871009 CC[C@@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O4/c1-3-33(43,29-18-39(2)21-38-29)25-14-27-30(28(36)15-25)34(24-8-10-26(35)11-9-24,44-20-32(19-41)12-13-32)40(31(27)42)17-23-6-4-22(16-37)5-7-23/h4-11,14-15,18,21,41,43H,3,12-13,17,19-20H2,1-2H3/t33-,34+/m0/s1 ZOWAIYZZMIRJLG-SZAHLOSFSA-N 427154 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 94 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 64000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427154&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733001 434321468 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871010 CC[C@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](OCC3(CO)CC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H32ClFN4O4/c1-3-33(43,29-18-39(2)21-38-29)25-14-27-30(28(36)15-25)34(24-8-10-26(35)11-9-24,44-20-32(19-41)12-13-32)40(31(27)42)17-23-6-4-22(16-37)5-7-23/h4-11,14-15,18,21,41,43H,3,12-13,17,19-20H2,1-2H3/t33-,34-/m1/s1 ZOWAIYZZMIRJLG-KKLWWLSJSA-N 427155 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-1-{[1-(hydroxymethyl)cyclopropyl]methoxy}-3-oxo-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 95 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 87000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427155&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733002 434321469 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871011 CC[C@@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32-,33+/m0/s1 CDUKUNZREUVQKN-FRJUPVQCSA-N 427156 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[I-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 96::US10981898, Example 96 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.640 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427156&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733003 434321470 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871012 CC[C@](O)(c1cn(C)cn1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)[C@](O[C@H]3CCOC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H30ClFN4O4/c1-3-32(41,29-18-38(2)20-37-29)24-14-27-30(28(35)15-24)33(43-26-12-13-42-19-26,23-8-10-25(34)11-9-23)39(31(27)40)17-22-6-4-21(16-36)5-7-22/h4-11,14-15,18,20,26,41H,3,12-13,17,19H2,1-2H3/t26-,32+,33+/m0/s1 CDUKUNZREUVQKN-WNNZTAQKSA-N 427157 4-{[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[I-hydroxy-1-(1-methyl-1H-imidazol-4-yl)propyl]-3-oxo-1-[(3S)-oxolan-3-yloxy]-2,3-dihydro-1H-isoindol-2-yl]methyl}benzonitrile::US10544132, Example 97::US10981898, Example 97 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 45000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427157&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733004 434321471 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871013 CO[C@]1(N([C@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29+,31-/m1/s1 HZTQINJSGAPBLS-JEVIFJNESA-N 427158 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-(4-fluorooxan-4-yl)-1-hydroxyethyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 98 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.800 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427158&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733005 434321472 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871014 CO[C@]1(N([C@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@@](C)(O)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-29(40,30(35)11-13-42-14-12-30)20-15-23-27(24(34)16-20)31(41-2,19-5-9-22(33)10-6-19)36(28(23)39)25(17-26(37)38)18-3-7-21(32)8-4-18/h3-10,15-16,25,40H,11-14,17H2,1-2H3,(H,37,38)/t25-,29-,31-/m1/s1 HZTQINJSGAPBLS-DSXODZLMSA-N 427159 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-(4-fluorooxan-4-yl)-1-hydroxyethyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 99 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 12.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427159&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733006 434321473 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871015 CCC(O)(c1ccn(C)n1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H30Cl2FN3O5/c1-4-31(42,27-15-16-37(2)36-27)21-17-24-29(25(35)18-21)32(43-3,20-7-11-23(34)12-8-20)38(30(24)41)26(13-14-28(39)40)19-5-9-22(33)10-6-19/h5-12,15-18,26,42H,4,13-14H2,1-3H3,(H,39,40)/t26-,31?,32+/m0/s1 ACCSRYKZIIOHIZ-LTZUXFEUSA-N 427160 US10544132, Example 100::US10981898, Example 100::US11236047, Example 100 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.30 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427160&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281496 434321474 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871016 CC[C@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO6/c1-3-31(41,30(36)12-14-43-15-13-30)21-16-24-28(25(35)17-21)32(42-2,20-6-10-23(34)11-7-20)37(29(24)40)26(18-27(38)39)19-4-8-22(33)9-5-19/h4-11,16-17,26,41H,3,12-15,18H2,1-2H3,(H,38,39)/t26-,31-,32+/m0/s1 HXHSKGLWTNIZIS-XBZWSRNISA-N 427161 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-(4-fluorooxan-4-yl)-1-hydroxypropyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 101::US10981898, Example 102 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 55000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427161&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733007 434321475 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871017 CC[C@@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO6/c1-3-31(41,30(36)12-14-43-15-13-30)21-16-24-28(25(35)17-21)32(42-2,20-6-10-23(34)11-7-20)37(29(24)40)26(18-27(38)39)19-4-8-22(33)9-5-19/h4-11,16-17,26,41H,3,12-15,18H2,1-2H3,(H,38,39)/t26-,31+,32+/m0/s1 HXHSKGLWTNIZIS-OODHRNECSA-N 427162 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-(4-fluorooxan-4-yl)-1-hydroxypropyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 102::US10544132, Example 110 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 17.0 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427162&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733008 434321476 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871018 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](C)(O)C1CCC1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO5/c1-29(38,18-4-3-5-18)20-14-23-27(24(33)15-20)30(39-2,19-8-12-22(32)13-9-19)34(28(23)37)25(16-26(35)36)17-6-10-21(31)11-7-17/h6-15,18,25,38H,3-5,16H2,1-2H3,(H,35,36)/t25-,29+,30+/m0/s1 BVCCIEZECAVANS-AWJLRTIGSA-N 427163 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-5-(1-cyclobutyl-1-hydroxyethyl)-7-fluoro-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 103 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 55000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427163&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733009 434321477 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871019 CO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@@](C)(O)C1CCC1)c1ccc(Cl)cc1 InChI=1S/C30H28Cl2FNO5/c1-29(38,18-4-3-5-18)20-14-23-27(24(33)15-20)30(39-2,19-8-12-22(32)13-9-19)34(28(23)37)25(16-26(35)36)17-6-10-21(31)11-7-17/h6-15,18,25,38H,3-5,16H2,1-2H3,(H,35,36)/t25-,29-,30+/m0/s1 BVCCIEZECAVANS-JPHFWNGBSA-N 427164 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-5-(1-cyclobutyl-1-hydroxyethyl)-7-fluoro-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 104 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 70000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427164&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733010 434321478 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871020 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N([C@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,20-12-14-42-15-13-20)22-16-25-29(26(35)17-22)32(41-2,21-6-10-24(34)11-7-21)36(30(25)39)27(18-28(37)38)19-4-8-23(33)9-5-19/h4-11,16-17,20,27,40H,3,12-15,18H2,1-2H3,(H,37,38)/t27-,31+,32-/m1/s1 TXTARTLLGHDDSD-RKVVATLDSA-N 427165 US10544132, Example 105 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 92000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427165&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733011 434321479 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871021 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,20-12-14-42-15-13-20)22-16-25-29(26(35)17-22)32(41-2,21-6-10-24(34)11-7-21)36(30(25)39)27(18-28(37)38)19-4-8-23(33)9-5-19/h4-11,16-17,20,27,40H,3,12-15,18H2,1-2H3,(H,37,38)/t27-,31+,32+/m0/s1 TXTARTLLGHDDSD-QUBLIXHFSA-N 427166 US10544132, Example 106::US11236047, Example 106 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 57000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427166&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281471 434321480 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871022 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-3-32(41,21-14-16-43-17-15-21)23-18-26-30(27(36)19-23)33(42-2,22-6-10-25(35)11-7-22)37(31(26)40)28(12-13-29(38)39)20-4-8-24(34)9-5-20/h4-11,18-19,21,28,41H,3,12-17H2,1-2H3,(H,38,39)/t28-,32-,33+/m0/s1 YDGNPXHTWKENIC-KXLBIAJQSA-N 427167 US10544132, Example 107::US11236047, Example 107 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 78000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427167&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281641 434321481 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871023 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-3-32(41,21-14-16-43-17-15-21)23-18-26-30(27(36)19-23)33(42-2,22-6-10-25(35)11-7-22)37(31(26)40)28(12-13-29(38)39)20-4-8-24(34)9-5-20/h4-11,18-19,21,28,41H,3,12-17H2,1-2H3,(H,38,39)/t28-,32+,33+/m0/s1 YDGNPXHTWKENIC-XEUSQTKLSA-N 427168 US10544132, Example 108::US10981898, Example 108::US11236047, Example 108 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6.10 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427168&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281545 434321482 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871024 CC[C@@](O)(c1cc2C(=O)N([C@@H](CCC([O-])=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C33H33Cl2F2NO6/c1-3-32(42,31(37)14-16-44-17-15-31)22-18-25-29(26(36)19-22)33(43-2,21-6-10-24(35)11-7-21)38(30(25)41)27(12-13-28(39)40)20-4-8-23(34)9-5-20/h4-11,18-19,27,42H,3,12-17H2,1-2H3,(H,39,40)/p-1/t27-,32+,33+/m0/s1 KQTPBMJSGVVRKO-SKTNCWGXSA-M 427169 US10544132, Example 109::US11236047, Example 109 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 92000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427169&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765594 434321483 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871025 CC[C@@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO6/c1-3-31(41,30(36)12-14-43-15-13-30)21-16-24-28(25(35)17-21)32(42-2,20-6-10-23(34)11-7-20)37(29(24)40)26(18-27(38)39)19-4-8-22(33)9-5-19/h4-11,16-17,26,41H,3,12-15,18H2,1-2H3,(H,38,39)/t26-,31+,32+/m0/s1 HXHSKGLWTNIZIS-OODHRNECSA-N 427162 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-(4-fluorooxan-4-yl)-1-hydroxypropyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 102::US10544132, Example 110 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 76000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427162&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733008 434321476 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871026 CCO[C@]1(N([C@@H](CC(O)=O)c2ccc(Cl)cc2)C(=O)c2cc(cc(F)c12)[C@](O)(CC)C1(F)CCOCC1)c1ccc(Cl)cc1 InChI=1S/C33H33Cl2F2NO6/c1-3-32(42,31(37)13-15-43-16-14-31)22-17-25-29(26(36)18-22)33(44-4-2,21-7-11-24(35)12-8-21)38(30(25)41)27(19-28(39)40)20-5-9-23(34)10-6-20/h5-12,17-18,27,42H,3-4,13-16,19H2,1-2H3,(H,39,40)/t27-,32+,33+/m0/s1 JMXJOWWAIDYRLU-SKTNCWGXSA-N 427171 US10544132, Example 111::US11236047, Example 111 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 61000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427171&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281526 434321484 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871027 CC[C@@](O)(c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(OC)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C34H36ClF2NO7/c1-4-33(42,32(37)15-17-45-18-16-32)23-19-26-30(27(36)20-23)34(44-3,22-7-9-24(35)10-8-22)38(31(26)41)28(13-14-29(39)40)21-5-11-25(43-2)12-6-21/h5-12,19-20,28,42H,4,13-18H2,1-3H3,(H,39,40)/t28-,33+,34+/m0/s1 NOKLTVPSPDXSBE-HUTUBIKLSA-N 427172 US10544132, Example 113::US11236047, Example 113 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 57000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427172&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281626 434321485 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871028 CCC(O)([C@H]1CC[C@H](O)CC1)c1cc2C(=O)N([C@@H](CCC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO6/c1-3-33(43,21-8-14-26(39)15-9-21)23-18-27-31(28(37)19-23)34(44-2,22-6-12-25(36)13-7-22)38(32(27)42)29(16-17-30(40)41)20-4-10-24(35)11-5-20/h4-7,10-13,18-19,21,26,29,39,43H,3,8-9,14-17H2,1-2H3,(H,40,41)/t21-,26-,29-,33?,34+/m0/s1 QJTCYWYDSIOJFY-OYLRFEPJSA-N 427173 US10544132, Example 114::US11236047, Example 114 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 81000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427173&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137405365 434321486 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871029 CC[C@@](O)(c1cc2C(=O)N(Cc3ccc(Cl)cc3OCC([O-])=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H31Cl2F2NO7/c1-3-31(41,30(36)10-12-43-13-11-30)21-14-24-28(25(35)15-21)32(42-2,20-5-8-22(33)9-6-20)37(29(24)40)17-19-4-7-23(34)16-26(19)44-18-27(38)39/h4-9,14-16,41H,3,10-13,17-18H2,1-2H3,(H,38,39)/p-1/t31-,32-/m1/s1 JJZSDEJWGNDCRG-ROJLCIKYSA-M 427174 US10544132, Example 115 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 73000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427174&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765549 434321487 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871030 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-3-30(39,19-10-12-41-13-11-19)21-14-25-27(26(34)15-21)31(40-2,20-5-8-22(32)9-6-20)35(28(25)36)17-18-4-7-23(33)16-24(18)29(37)38/h4-9,14-16,19,39H,3,10-13,17H2,1-2H3,(H,37,38)/t30-,31+/m0/s1 NOIABBKIABICFM-IOWSJCHKSA-N 427175 US10544132, Example 116 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 88000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427175&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281393 434321488 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871031 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H30Cl2FNO6/c1-3-30(39,19-10-12-41-13-11-19)21-14-25-27(26(34)15-21)31(40-2,20-5-8-22(32)9-6-20)35(28(25)36)17-18-4-7-23(33)16-24(18)29(37)38/h4-9,14-16,19,39H,3,10-13,17H2,1-2H3,(H,37,38)/t30-,31-/m1/s1 NOIABBKIABICFM-FIRIVFDPSA-N 427176 US10544132, Example 117::US11236047, Example 117 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 45000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427176&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281388 434321489 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871032 CCO[C@]1(N(Cc2ccc(Cl)cc2C(O)=O)C(=O)c2cc(cc(F)c12)[C@](O)(CC)C1CCOCC1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,20-11-13-41-14-12-20)22-15-26-28(27(35)16-22)32(42-4-2,21-6-9-23(33)10-7-21)36(29(26)37)18-19-5-8-24(34)17-25(19)30(38)39/h5-10,15-17,20,40H,3-4,11-14,18H2,1-2H3,(H,38,39)/t31-,32+/m0/s1 DLUFTCNJNCOQGS-AJQTZOPKSA-N 427177 US10544132, Example 118 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 87000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427177&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281631 434321490 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871033 CC[C@@](O)(c1cc2C(=O)N(Cc3ccc(C)cc3C(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H32ClF2NO6/c1-4-31(40,30(35)11-13-42-14-12-30)22-16-25-27(26(34)17-22)32(41-3,21-7-9-23(33)10-8-21)36(28(25)37)18-20-6-5-19(2)15-24(20)29(38)39/h5-10,15-17,40H,4,11-14,18H2,1-3H3,(H,38,39)/t31-,32-/m1/s1 XFQWQHWLXCPJND-ROJLCIKYSA-N 427178 US10544132, Example 119::US11236047, Example 119 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 54000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427178&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281401 434321491 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871034 CC[C@@](O)(c1cc2C(=O)N(Cc3ccc(OC)cc3C([O-])=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCOCC1 InChI=1S/C32H32ClF2NO7/c1-4-31(40,30(35)11-13-43-14-12-30)21-15-25-27(26(34)16-21)32(42-3,20-6-8-22(33)9-7-20)36(28(25)37)18-19-5-10-23(41-2)17-24(19)29(38)39/h5-10,15-17,40H,4,11-14,18H2,1-3H3,(H,38,39)/p-1/t31-,32-/m1/s1 AMRXPNINJISJEN-ROJLCIKYSA-M 427179 US10544132, Example 120::US11236047, Example 120 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 76000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427179&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765586 434321492 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871035 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3C(C)(C)C([O-])=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H36Cl2FNO6/c1-5-33(42,21-12-14-44-15-13-21)23-16-26-29(28(37)17-23)34(43-4,22-7-10-24(35)11-8-22)38(30(26)39)19-20-6-9-25(36)18-27(20)32(2,3)31(40)41/h6-11,16-18,21,42H,5,12-15,19H2,1-4H3,(H,40,41)/p-1/t33-,34+/m0/s1 DMHHJJRAOBKLND-SZAHLOSFSA-M 427180 US10544132, Example 121::US11236047, Example 121 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 93000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427180&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 145765546 434321493 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871036 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3CC([O-])=O)C(OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,21-10-12-42-13-11-21)23-16-26-29(27(35)17-23)32(41-2,22-5-8-24(33)9-6-22)36(30(26)39)18-19-4-7-25(34)14-20(19)15-28(37)38/h4-9,14,16-17,21,40H,3,10-13,15,18H2,1-2H3,(H,37,38)/p-1/t31-,32?/m0/s1 KSQHEVCOEVTEOI-CYZZXXEPSA-M 427181 US10544132, Example 122 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 88000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427181&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733012 434321494 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871037 CC[C@@](O)(C1CCOCC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3CC(O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H32Cl2FNO6/c1-3-31(40,21-10-12-42-13-11-21)23-16-26-29(27(35)17-23)32(41-2,22-5-8-24(33)9-6-22)36(30(26)39)18-19-4-7-25(34)14-20(19)15-28(37)38/h4-9,14,16-17,21,40H,3,10-13,15,18H2,1-2H3,(H,37,38)/t31-,32-/m1/s1 KSQHEVCOEVTEOI-ROJLCIKYSA-N 427182 US10544132, Example 123::US11236047, Example 123 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 42000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427182&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281591 434321495 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871038 CC[C@](O)(C1CCOCC1)c1cc2C(=O)N([C@@H]([C@H](C)C(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H34Cl2FNO6/c1-4-32(41,21-13-15-43-16-14-21)23-17-26-28(27(36)18-23)33(42-3,22-7-11-25(35)12-8-22)37(30(26)38)29(19(2)31(39)40)20-5-9-24(34)10-6-20/h5-12,17-19,21,29,41H,4,13-16H2,1-3H3,(H,39,40)/t19-,29-,32-,33+/m0/s1 JDCHPEZNOKLHPK-KJEAJVGRSA-N 427183 US10544132, Example 124::US11236047, Example 124 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 80000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427183&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281467 434321496 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871039 CC[C@](C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-3-29(2,40)20-12-23-27(24(34)13-20)31(19-6-10-22(33)11-7-19,42-17-30(35)15-41-16-30)36(28(23)39)25(14-26(37)38)18-4-8-21(32)9-5-18/h4-13,25,40H,3,14-17H2,1-2H3,(H,37,38)/t25-,29-,31+/m0/s1 NAMQEWAUDBCILZ-ZITMISKDSA-N 427184 US10544132, Example 125::US10981898, Example 126 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 18000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427184&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733014 434321497 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871040 CC[C@@](C)(O)c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OCC3(F)COC3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C31H29Cl2F2NO6/c1-3-29(2,40)20-12-23-27(24(34)13-20)31(19-6-10-22(33)11-7-19,42-17-30(35)15-41-16-30)36(28(23)39)25(14-26(37)38)18-4-8-21(32)9-5-18/h4-13,25,40H,3,14-17H2,1-2H3,(H,37,38)/t25-,29+,31+/m0/s1 NAMQEWAUDBCILZ-FPHQXIGGSA-N 427185 US10544132, Example 126 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.90 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427185&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733015 434321498 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871041 CC[C@@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)c1ccccn1 InChI=1S/C32H27Cl2FN2O5/c1-3-31(41,27-6-4-5-15-36-27)21-16-24-29(25(35)17-21)32(42-2,20-9-13-23(34)14-10-20)37(30(24)40)26(18-28(38)39)19-7-11-22(33)12-8-19/h4-17,26,41H,3,18H2,1-2H3,(H,38,39)/t26-,31+,32+/m0/s1 KHSRSNYUTBONQS-OODHRNECSA-N 427186 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(pyridin-2-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 127 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 4.50 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427186&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733016 434321499 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871042 CC[C@](O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)c1ccccn1 InChI=1S/C32H27Cl2FN2O5/c1-3-31(41,27-6-4-5-15-36-27)21-16-24-29(25(35)17-21)32(42-2,20-9-13-23(34)14-10-20)37(30(24)40)26(18-28(38)39)19-7-11-22(33)12-8-19/h4-17,26,41H,3,18H2,1-2H3,(H,38,39)/t26-,31-,32+/m0/s1 KHSRSNYUTBONQS-XBZWSRNISA-N 427187 (3S)-3-(4-chlorophenyl)-3-[(1R)-1-(4-chlorophenyl)-7-fluoro-5-[1-hydroxy-1-(pyridin-2-yl)propyl]-1-methoxy-3-oxo-2,3-dihydro-1H-isoindol-2-yl]propanoic Acid::US10544132, Example 128::US10981898, Example 127 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 39000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427187&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733017 434321500 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871043 CCC(O)(c1cc2C(=O)N(Cc3ccc(Cl)cc3S(C)(=O)=O)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCNCC1 InChI=1S/C31H32Cl2F2N2O5S/c1-4-30(39,29(35)11-13-36-14-12-29)21-15-24-27(25(34)16-21)31(42-2,20-6-9-22(32)10-7-20)37(28(24)38)18-19-5-8-23(33)17-26(19)43(3,40)41/h5-10,15-17,36,39H,4,11-14,18H2,1-3H3/t30?,31-/m1/s1 YMXGZYIWCPLVGI-NLIBRCFJSA-N 427188 US10544132, Example 129::US11236047, Example 129 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 90000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427188&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281595 434321501 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871044 CC[C@](O)(C1CCN(C)CC1)c1cc2C(=O)N(Cc3ccc(cc3)C#N)C(O[C@@H]3C[C@H](O)C3)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C35H37ClFN3O4/c1-3-34(43,24-12-14-39(2)15-13-24)26-16-30-32(31(37)17-26)35(44-29-18-28(41)19-29,25-8-10-27(36)11-9-25)40(33(30)42)21-23-6-4-22(20-38)5-7-23/h4-11,16-17,24,28-29,41,43H,3,12-15,18-19,21H2,1-2H3/t28-,29+,34-,35?/m0/s1 RVEVEKZOUQPWSR-JOEBACTPSA-N 427189 US10544132, Example 130::US11236047, Example 130 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 98000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427189&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 137411586 434321502 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871045 CCC(O)(c1cc2C(=O)N([C@@H](CC(O)=O)c3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1)C1(F)CCN(C)CC1 InChI=1S/C33H34Cl2F2N2O5/c1-4-32(43,31(37)13-15-38(2)16-14-31)22-17-25-29(26(36)18-22)33(44-3,21-7-11-24(35)12-8-21)39(30(25)42)27(19-28(40)41)20-5-9-23(34)10-6-20/h5-12,17-18,27,43H,4,13-16,19H2,1-3H3,(H,40,41)/t27-,32?,33+/m0/s1 UASWWYBCWGDNKX-ATPTUWPCSA-N 427190 US10544132, Example 131 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 89000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427190&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281617 434321503 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871046 CC[C@](O)(C1CCN(CC(=O)OC(C)(C)C)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C36H41Cl2FN2O5/c1-6-35(44,24-15-17-40(18-16-24)22-31(42)46-34(2,3)4)26-19-29-32(30(39)20-26)36(45-5,25-9-13-28(38)14-10-25)41(33(29)43)21-23-7-11-27(37)12-8-23/h7-14,19-20,24,44H,6,15-18,21-22H2,1-5H3/t35-,36+/m0/s1 RGCRBSVSBVXCDO-MPQUPPDSSA-N 427191 US10544132, Example 132 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 43000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427191&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281894 434321504 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871047 CC[C@@](O)(C1CCN(CC(=O)OC(C)(C)C)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C36H41Cl2FN2O5/c1-6-35(44,24-15-17-40(18-16-24)22-31(42)46-34(2,3)4)26-19-29-32(30(39)20-26)36(45-5,25-9-13-28(38)14-10-25)41(33(29)43)21-23-7-11-27(37)12-8-23/h7-14,19-20,24,44H,6,15-18,21-22H2,1-5H3/t35-,36-/m1/s1 RGCRBSVSBVXCDO-LQFQNGICSA-N 427192 US10544132, Example 133 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 6000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427192&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281629 434321505 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871048 CC[C@@](O)(C1CCN(CC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H33Cl2FN2O5/c1-3-31(41,21-12-14-36(15-13-21)19-28(38)39)23-16-26-29(27(35)17-23)32(42-2,22-6-10-25(34)11-7-22)37(30(26)40)18-20-4-8-24(33)9-5-20/h4-11,16-17,21,41H,3,12-15,18-19H2,1-2H3,(H,38,39)/t31-,32-/m1/s1 MFPOPVHVIGVWNK-ROJLCIKYSA-N 427193 US10544132, Example 134::US11236047, Example 135 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.10 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427193&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281491 434321506 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871049 CC[C@](O)(C1CCN(CC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C32H33Cl2FN2O5/c1-3-31(41,21-12-14-36(15-13-21)19-28(38)39)23-16-26-29(27(35)17-23)32(42-2,22-6-10-25(34)11-7-22)37(30(26)40)18-20-4-8-24(33)9-5-20/h4-11,16-17,21,41H,3,12-15,18-19H2,1-2H3,(H,38,39)/t31-,32+/m0/s1 MFPOPVHVIGVWNK-AJQTZOPKSA-N 427194 US10544132, Example 135::US10981898, Example 134::US11236047, Example 134 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 40000 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427194&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281570 434321507 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871050 CC[C@](O)(C1CCN(CCC(=O)OC)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)[C@](OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C34H37Cl2FN2O5/c1-4-33(42,23-13-16-38(17-14-23)18-15-30(40)43-2)25-19-28-31(29(37)20-25)34(44-3,24-7-11-27(36)12-8-24)39(32(28)41)21-22-5-9-26(35)10-6-22/h5-12,19-20,23,42H,4,13-18,21H2,1-3H3/t33-,34+/m0/s1 ATEBGPCVCPBSLM-SZAHLOSFSA-N 427195 US10544132, Example 136::US10981898, Example 137::US11236047, Example 136 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 1.30 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427195&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 135281761 434321508 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 871051 CC[C@](O)(C1CCN(CCC(O)=O)CC1)c1cc2C(=O)N(Cc3ccc(Cl)cc3)C(OC)(c2c(F)c1)c1ccc(Cl)cc1 InChI=1S/C33H35Cl2FN2O5/c1-3-32(42,22-12-15-37(16-13-22)17-14-29(39)40)24-18-27-30(28(36)19-24)33(43-2,23-6-10-26(35)11-7-23)38(31(27)41)20-21-4-8-25(34)9-5-21/h4-11,18-19,22,42H,3,12-17,20H2,1-2H3,(H,39,40)/t32-,33?/m0/s1 ZKUGFHUACFYRES-JEFWXSHNSA-N 427196 US10544132, Example 137 E3 ubiquitin-protein ligase Mdm2 Homo sapiens 0.570 US Patent 10.7270/Q27H1N06 aid1804114 US10544132 Chessari, G; Howard, S; Buck, IM; Cons, BD; Johnson, CN; Holvey, RS; Rees, DC; St. Denis, JD; Tamanini, E; Golding, BT; Hardcastle, IR; Cano, CF; Miller, DC; Noble, ME; Griffin, RJ; Osborne, JD; Peach, J; Lewis, A; Hirst, KL; Whittaker, BP; Watson, DW; Mitchell, DR 1/28/2020 11/7/2020 ASTEX THERAPEUTICS LIMITED; CANCER RESEARCH TECHNOLOGY LIMITED http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=427196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3720&target=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=427196&enzyme=E3+ubiquitin-protein+ligase+Mdm2&column=ki&startPg=0&Increment=50&submit=Search 154733018 434321509 1 MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP 1T4E,1T4F,1YCR,1Z1M,2C6A,2C6B,2GV2,2HDP,2LZG,2M86,2MPS,2VJE,2VJF,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4XXB,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5MNJ,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,6SQO,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8BGU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8